Leadership & Pay ·
SELLAS Life Sciences Group, Inc. amended its executive compensation and severance agreements for CEO Dr. Angelos…
SLSSELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. amended its executive compensation and severance agreements for CEO Dr. Angelos Stergiou, CFO John Burns, and CDO Dragan Cicic on June 24, 2026. The amendments include lump-sum change-in-control severance benefits for the CEO and enhanced severance packages for the CFO and CDO, including base salary, target bonuses, and COBRA reimbursement. SELLAS Life Sciences Group, Inc. is a biopharmaceutical company focused on developing clinical-stage life sciences products.